For instance, in conditions such as neuroglioma and NSCLC, the silencing of the PCSK9 gene has been shown to activate cancer cell apoptosis through pathways involving caspase-3 and XIAP/p-Akt [97]. This evidence concerns the gene PCSK9 and cancer.